Topics

Companies Related to "Late Focus LATE Overlooked Brain Disease" [Most Relevant Company Matches] RSS

11:18 EDT 21st September 2019 | BioPortfolio

Here are the most relevant search results for "Late Focus LATE Overlooked Brain Disease" found in our extensive corporate database of over 50,000 company records.

Showing "Late Focus LATE Overlooked Brain Disease" Companies 1–25 of 5,100+

Extremely Relevant

Salix Pharmaceuticals

Salix Pharmaceuticals is dedicated to being the leading specialty pharmaceutical company providing products to gastroenterologists and their patients. In-license selective late-stage/marketed products Our "search and development" efforts are designed to identify and acquire late-stage and/or marketed proprietary pharmaceutical products for the treatment of gastrointestinal disease that have an...


Relevant

Perlegen Sciences, Inc.

Perlegen Sciences was formed in late 2000 to accelerate the development of high-resolution, whole genome scanning. Three key factors differentiate Perlegen from other organizations involved in the science of genomics: Our genome scanning focuses exclusively on DNA; not RNA expression, not proteins, not enzymes, not metabolism. Just DNA. Period. The beauty of DNA is that it is finite. It is effecti...

SciFluor Life Sciences, LLC

SciFluor Life Sciences is an Allied Minds-funded company with a late-stage fluorination technology that improves drug properties such as metabolic stability, potency, bioavailability, and blood-brain barrier penetration. The company's late-stage fluorination technology, and its companion portfolio of fluorinated pharmaceuticals, are licensed exclusively fr...


HST Global, Inc.

HST Global, Inc. is an Integrated Biotechnology Health and Wellness company that is developing and or acquiring a network of Wellness Centers worldwide that are primarily focused on the immunotherapy and alternative treatment of late stage cancer. In addition, the company intends to acquire innovative products for the treatment of late stage cancer. In thi...

Neurobiological Technologies

Neurobiological Technologies, Inc. (NTI) (NASDAQ: NTII) is a biotechnology company engaged in the business of acquiring and developing central nervous system (CNS) related drug candidates. The company is focused on therapies for neurological conditions that occur in connection with dementia, Alzheimer's disease, ischemic stroke, neuropathic pain, and brain cancer. The company employs a strategy ...

C2N Diagnostics, LLC

C2N Diagnostics, LLC (www.c2ndiagnostics.com) formed in late 2007 by scientific co-founders Drs. David Holtzman and Randall Bateman of Washington University School of Medicine in St. Louis, the Washington University Office of Technology Management, and LifeTech Research, a Maryland-based technology research and commercialization firm (www.lifetechresearch....

Horizon Therapeutics, Inc.

Horizon Therapeutics, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of mild-to-moderate pain and arthritis. Horizon's clinical portfolio includes innovative combination therapies in early- and late-stage development that are designed to improve safety, efficacy and patient compliance. For more information about the ...

C2N Diagnostics, InterVivo Solutions, and inviCRO

C2N Diagnostics, LLC (www.c2ndiagnostics.com) formed in late 2007 by scientific co-founders Drs. David Holtzman and Randall Bateman of Washington University School of Medicine in St. Louis, the Washington University Office of Technology Management, and LifeTech Research, a Maryland-based technology research and commercialization firm (www.lifetechresearch....

Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals is a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology. The Company’s strategy is comprised of acquiring, developing and commercializing a broad and diverse pipeline of late-stage clinical and commercial products. The Company markets two oncol...

InCytu Incorporated

InCytu is a privately held biotherapeutic company with its primary operations located in Rhode Island. The Company is targeting its Cellarium vaccine at treating late stage melanoma tumors while gathering promising preliminary data using the Cellarium to treat other cancers. InCytu has established a manufacturing facility for creating Cellarium devices in ...

Spectrum Pharmaceuticals and Allos Therapeutics, Inc.

Spectrum Pharmaceuticals, a biotechnology company with a primary focus in oncology and hematology, currently markets two oncology drugs, FUSILEV® and ZEVALIN®. In addition, Spectrum has two drugs, apaziquone and belinostat, in late stage development. Spectrum also has a diversified pipeline of novel drug candidates. Spectrum’s strategy is compri...

Recordati Rare Diseases Canada Inc.

Recordati Rare Diseases Canada Inc. is a biopharmaceutical company committed to providing often overlooked orphan therapies to underserved rare disease communities in Canada. Recordati Rare Diseases Canada Inc. and our sister company, Orphan Europe, are part of the rare disease business within the Recordati Group, a public global pharmaceutical company co...

MolMed S.p.A.

Since year 2000, MolMed has evolved into a biotechnology drug-developing company, with a primary focus on novel cancer therapies. Today, MolMed is an integrated company covering all functions, from discovery to proof of clinical efficacy.MolMed’s business strategy is based on five key points: Developing novel therapies by demonstrating proof of concept in small, well-defined patient populat...

Syngenta

Syngenta is a new company, with a proud history.Syngenta was formed in late 2000, bringing together the strengths of Novartis Agribusiness and Zeneca Agrochemicals to create a new global company with an exclusive focus on agribusiness.

Neuronix Ltd.

Established in 2008, Neuronix has developed a non-invasive technology-based treatment of brain conditions and their related symptoms, with a focus on Alzheimer's Disease (“AD”). Neuronix's proprietary (patent pending) technology is based on the concurrent use of non-invasive Transcranial Magnetic Stimulations (“TMS”) to specific regions...

BRAIN TRAINING

Keep your brain sharp and in shape with 'Dr. Kawashima's Brain Training: How Old Is Your Brain?'Inspired by the theories of neuroscientist Dr. Ryuta Kawashima, 'Brain Training' is a collection of simple daily exercises that help stimulate the brain and keep it young

CorTechs Labs

CorTechs Labs develops and markets breakthrough medical device software solutions capable of automatically segmenting and quantifying brain structures, making quantitative analysis of the human brain a routine part of clinical practice. CorTechs Labs’ cutting-edge brain imaging analysis provides neurologists, radiologists and clinical researchers worldwide with a convenient and cost-effectiv...

Symbiomix Therapeutics

Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company with a focus on women’s health. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut. The Company is also investigating other indications for SYM-1219 and exploring additional novel products. Please visit www.symbiomix.com and follow t...

Aerpio Therapeutics

Aerpio Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on advancing innovative therapies for the treatment of diabetic eye disease and inflammatory bowel disease. Aerpio is a leader in the development of small molecule drugs based on Tie-2 activation and the stabilization of Hypoxia-inducible Factor 1α (HIF-1α). The company’s ...

BrainScope Company, Inc

BrainScope Company, Inc is a privately held medical neurotechnology company developing a new generation of portable, simple-to-use, non-invasive instruments to rapidly, and objectively assess brain function at the initial point of care. The portability and ease-of-use of these tools in development could aid United States military Health Service Support personnel in promptly diagnosing Traumatic Br...

Aerpio Therapeutics, Inc.

Aerpio Therapeutics, Inc. is a clinical‐stage biopharmaceutical company focused on advancing innovative therapies for the treatment of diabetic eye disease and inflammatory bowel disease. Aerpio is a leader in the development of small molecule drugs based on Tie2 activation and the stabilization of Hypoxia-inducible Factor 1α (HIF‐1α). The Company...

Mind-NRG

Mind-NRG is devoted to the development of NRG-101 in psychiatric and neurologic diseases. NRG-101 is a neurotrophic factor with disease modifying potential that naturally crosses the blood-brain barrier through a receptor-mediated transport to reach its target in the brain. Currently at the pre-clinical stage, NRG-101 is being developed to treat d...

NicOx S.A

NicOx is a product-driven biopharmaceutical company dedicated to the development of nitric oxide-donating drugs to meet unmet medical needs.NicOx is targeting the therapeutic areas of inflammation and cardiovascular disease.The Company’s resources are focused on its two lead compounds in late stage development for the treatment of osteoarthritis and Peripheral Arterial Obstructive Disease (PAOD)...

Revivicor, Inc

Revivicor’s vision is the commercialization of therapies that can treat and cure serious human disease through regenerative medicine; namely, the replacement of cells, tissues, and organs. Revivicor's focus is the commercialization of treatments for diabetes and whole organ transplantation, developed from the significant advances made in the fields of xenografts and tolerance technologies, which...

EUSA Pharma Inc

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight marketed products, including Caphosol(R) for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high dose chemotherapy, Erwinas...


More From BioPortfolio on "Late Focus LATE Overlooked Brain Disease"

Quick Search

Corporate Database Quicklinks